Scoop
Software for drug developers that turns study and manufacturing data into pre-clinical regulatory submissions (IND) drafted with traceability to every source file, then keeps the filings reconciled as new results arrive.
Product
Selected offerings — the AI products recorded here, not the vendor's full catalogue.
-
Scoop Application
Drafting and upkeep of pre-clinical regulatory submissions: upload study reports and manufacturing packages, get submission-ready narratives traced to source files, flagged conflicts across sections, and regenerated text when new data arrives; sold by contact, no price published.
Similar products 65
No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.
Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.
Sources
- Total funding
-
Pages read for this record state no funding total. Tried the home and terms pages and the company's YC profile.
- Valuation
-
Pages read for this record state no valuation. Tried the home and terms pages and the company's YC profile.
- Founded
-
Company disclosure · 18 Oct 2026
Own YC profile lists Founded: 2025; scooplabs.ai states no founding year.
- Public listing
-
No listing on the pages read; treated as private.
- Description
-
Official documentation · 18 Oct 2026
Home page: "AI-native drafting and continuous maintenance for pre-clinical regulatory submissions." The brand differs from the operating entity named in the terms.
Something wrong here? Send a correction — quote this company id: scoop.